---
---

# 42 U.S.C., USLM ref /us/usc/t42/s287d–1

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../..//us/usc/t42/ch6A/schIII/ptF/m__us_usc_t42_s287d.md) | [Next](./../../../../../..//us/usc/t42/ch6A/schIII/ptF/m__us_usc_t42_s287d–2.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs287d%E2%80%931)

## § 287d–1. National data system and clearinghouse on research on women’s health

    (a) __Data system__ 

        (1) The Director of NIH, in consultation with the Director of the Office and the Director of the National Library of Medicine, shall establish a data system for the collection, storage, analysis, retrieval, and dissemination of information regarding research on women’s health that is conducted or supported by the national research institutes. Information from the data system shall be available through information systems available to health care professionals and providers, researchers, and members of the public.

        (2) The data system established under paragraph (1) shall include a registry of clinical trials of experimental treatments that have been developed for research on women’s health. Such registry shall include information on subject eligibility criteria, sex, age, ethnicity or race, and the location of the trial site or sites. Principal investigators of such clinical trials shall provide this information to the registry within 30 days after it is available. Once a trial has been completed, the principal investigator shall provide the registry with information pertaining to the results, including potential toxicities or adverse effects associated with the experimental treatment or treatments evaluated.

    (b) __Clearinghouse__ 

        The Director of NIH, in consultation with the Director of the Office and with the National Library of Medicine, shall establish, maintain, and operate a program to provide information on research and prevention activities of the national research institutes that relate to research on women’s health.

([July 1, 1944, ch. 373][/us/act/1944-07-01/ch373], title IV, § 486A, as added [Pub. L. 103–43, title I, § 141(a)(3)][/us/pl/103/43/s141/a/3], June 10, 1993, [107 Stat. 138][/us/stat/107/138].)

----------

[Previous](./../../../../../..//us/usc/t42/ch6A/schIII/ptF/m__us_usc_t42_s287d.md) | [Next](./../../../../../..//us/usc/t42/ch6A/schIII/ptF/m__us_usc_t42_s287d–2.md) | [Root of Title](./../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs287d%E2%80%931)

----------
----------

[/us/act/1944-07-01/ch373]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1944-07-01%2Fch373
[/us/pl/103/43/s141/a/3]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F103%2F43%2Fs141%2Fa%2F3
[/us/stat/107/138]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F107%2F138


